Rekindling hope for patients through innovation and dedication
SURGENEX® is committed to turning innovative science into medical solutions that bring value and hope to patients worldwide. Every day we work together to address unmet medical needs focusing on soft tissue damage, wounds, burns, osteoarthritis, rheumatoid arthritis, tendinitis, plantar fasciitis, and other therapeutic areas while leveraging new research technologies with amniotic membrane allograft treatments. We remain dedicated to meeting patients' needs, and support for them will never waiver.
At SURGENEX®, we’re focused pioneering the future today.
Click here to learn more about SURGENEX® mission statement
SurForce® Amniotic Membrane Allograft can be used for a wide range of medical applications, from minor ailments to complex surgeries.
Research shows amniotic membrane tissues aid in the reduction of pain and inflammation, promote soft tissue growth, minimize scar tissue, and is immune-evasive, allowing for highly beneficial clinical outcomes.
SurForce® utilizes properties of the amniotic membrane to create a barrier, cushion, and support for damaged tissues. SurForce® also contains a vital natural mechanism called a scaffold that aids in healing these damaged areas.
|15 min||1-2 hrs||2-4 hrs|
SurForce® is an injectable flowable Amniotic Membrane Allograft, derived from a donated placenta via C-section delivery. Within the placenta is the amniotic membrane, which supplies an abundant resource of regenerative cellular tissues, and is surgically dissected and processed using our proprietary Excellion® process. SurForce® is manufactured using this patented process to remove the chorion, filter out excess cellular debris, and purify the amniotic membrane allograft. The results yield the highest concentration of amniotic membrane on the market today.